MHRA Recall Natzon 0.4 mg Sublingual Tablets Recalled after Printing Mix Up
The Medicines and Healthcare products Regulatory Agency (MHRA) are asking people to check their dispensed cartons of the opoid withdrawal drug Natzon 0.4 mg Sublingual Tablets from two batches 13D22 and 13D24. A carton printing error means that some pack may contain Buprenorphine 8 mg Sublingual Tablets in Natzon 0.4 mg cartons.
Batch number Expiry Date Pack Size First Distributed
13D22 April 2016 1 x 7 12 August 2013
13D24 April 2016 1 x 7 22 August 2013
There have been two reported cases of this so and it is thought a maximum of 300 packs may have been affected. Natzon 0.4 mg and Buprenorphone 8 mg are used to treat recovering drug addicts and help them with withdrawal.